The number of initial public offerings by healthcare companies accounted for about 11 of the 22 IPOS in the second quarter. Still, venture-backed merger and acquisition activity has been sluggish in this sector for the quarter. But in its quarterly earnings call with analysts, Safeguard Scientifics CEO Stephen Zarrilli expressed guarded optimism about having some […]
The developer of a digital medical device that tests for different respiratory illnesses, such as flu A and B strains and strep A, sees additional scope for the respiratory test as a testing platform for sexually transmitted diseases along with a broader range of infectious diseases. The BD Veritor System, developed by Alverix and marketed […]
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Indianapolis drug maker Eli Lilly & Co. (NYSE:LLY) has agreed to pay up to $800 million for Avid Radiopharmaceuticals, the Philadelphia developer of a tracing agent that can help diagnose Alzheimer's disease. The tracing agent, florbetapir F 18 -- which last week topped the Cleveland Clinic's Top 10 Medical Innovations list for 2011 -- is coupled with a PET scan to allow doctors to see inside patients' brains to detect beta-amyloid plaques, the tell-tale signature of Alzheimer's.